Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (01349) Announces November 2025 Monthly Return on Movements in Securities

Bulletin Express

2025/12/01

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (01349) published a monthly return on its movements in securities for November 2025. The company’s total registered share capital remained at RMB 103,657,210 as of the end of the reporting period, with no change from the previous month. This includes 326,000,000 H shares, listed on the Stock Exchange of Hong Kong, and 710,572,100 A shares, listed on the STAR Market of the Shanghai Stock Exchange.

According to the announcement, there were no changes in the number of issued shares or the level of treasury shares. The company did not issue any share options, warrants, or convertible securities during the month. The concept of authorized share capital is not applicable under the company’s jurisdiction, and the information provided refers to registered share capital.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1141438614"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141438614\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141438614?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 17:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141438614","market":"us","top_or_hot":-1,"title":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (01349) Announces November 2025 Monthly Return on Movements in Securities","media":"Bulletin Express","content":"<p>Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (01349) published a monthly return on its movements in securities for November 2025. The company’s total registered share capital remained at RMB 103,657,210 as of the end of the reporting period, with no change from the previous month. This includes 326,000,000 H shares, listed on the Stock Exchange of Hong Kong, and 710,572,100 A shares, listed on the STAR Market of the Shanghai Stock Exchange.</p>\n<p>According to the announcement, there were no changes in the number of issued shares or the level of treasury shares. The company did not issue any share options, warrants, or convertible securities during the month. The concept of authorized share capital is not applicable under the company’s jurisdiction, and the information provided refers to registered share capital.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (01349) Announces November 2025 Monthly Return on Movements in Securities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Fudan-Zhangjiang Bio-Pharmaceutical (01349) Announces November 2025 Monthly Return on Movements in Securities\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-12-01 17:21</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (01349) published a monthly return on its movements in securities for November 2025. The company’s total registered share capital remained at RMB 103,657,210 as of the end of the reporting period, with no change from the previous month. This includes 326,000,000 H shares, listed on the Stock Exchange of Hong Kong, and 710,572,100 A shares, listed on the STAR Market of the Shanghai Stock Exchange.</p>\n<p>According to the announcement, there were no changes in the number of issued shares or the level of treasury shares. The company did not issue any share options, warrants, or convertible securities during the month. The concept of authorized share capital is not applicable under the company’s jurisdiction, and the information provided refers to registered share capital.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01349","symbol_name":"復旦張江","start_time":0,"source_url":"","article_id":"1141438614","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141438614","pubTimestamp":1764580893,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (01349) published a monthly return on its movements in securities for November 2025. The company’s total registered share capital remained at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01349":"复旦张江"},"translate_title":"上海复旦张江生物制药(01349)公布2025年11月证券变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01349":1},"content_text":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (01349) published a monthly return on its movements in securities for November 2025. The company’s total registered share capital remained at RMB 103,657,210 as of the end of the reporting period, with no change from the previous month. This includes 326,000,000 H shares, listed on the Stock Exchange of Hong Kong, and 710,572,100 A shares, listed on the STAR Market of the Shanghai Stock Exchange.\nAccording to the announcement, there were no changes in the number of issued shares or the level of treasury shares. The company did not issue any share options, warrants, or convertible securities during the month. The concept of authorized share capital is not applicable under the company’s jurisdiction, and the information provided refers to registered share capital.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}